Aristotle Capital Boston, LLC
+0.13%
3M Return
$39.680
-0.881 (-2.22%)At close
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.
Guardian Pharmacy Services Inc is a good buy right now, as it has a current price of $41.28, significantly below the analyst consensus target of $49.81, indicating a potential upside of approximately 20.8%. Additionally, the company reported a gross margin of 22.75% in Q2 2026, reflecting strong profitability. The main risk is the recent 5-day change of -2.60%, indicating short-term volatility.

Keybanc Initiates Coverage of Guardian Pharmacy Services with Overweight Rating

Latest Wall Street Ratings Overview

Guardian Pharmacy Acquires Nautilus Pharmacy Assets to Enhance LTC Services

Guardian Pharmacy Services to Participate in Jefferies Healthcare Conference

Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.
Guardian Pharmacy Services Inc is a good buy right now, as it has a current price of $41.28, significantly below the analyst consensus target of $49.81, indicating a potential upside of approximately 20.8%. Additionally, the company reported a gross margin of 22.75% in Q2 2026, reflecting strong profitability. The main risk is the recent 5-day change of -2.60%, indicating short-term volatility.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.